Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid in chronic hepatitis C
NCT00200343Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jul 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in hepatitis C (HCV), sponsored by Mitsubishi Tanabe Pharma. Started Jul 2002; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00200343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200343.